Fractyl Health Ratios (2023-2025) | GUTS

Ratios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 40.00%34.72%30.56%71.43%42.42%44.19%50.00%100.00%
EBT Margin -233,800.00%-16,279.17%-37,908.33%-178,828.57%-61,951.52%-50,255.81%-163,192.86%-816,133.33%
EBIT Margin -242,140.00%-16,493.06%-38,536.11%-185,442.86%-65,278.79%-53,453.49%-169,957.14%-840,333.33%
EBITDA Margin -242,140.00%-16,493.06%-38,536.11%-185,442.86%-65,278.79%-53,453.49%-169,957.14%-840,333.33%
Operating Margin -242,140.00%-16,493.06%-38,536.11%-185,442.86%-65,278.79%-53,453.49%-169,957.14%-840,333.33%
Net Margin -323,360.00%-47,937.50%-55,772.22%-335,857.14%-15,330.30%-40,067.44%-165,521.43%-832,333.33%
FCF Margin -191,400.00%-16,265.28%-31,016.67%-153,357.14%-38,696.97%-44,179.07%-130,371.43%-575,566.67%
Efficiency
Inventory Average 0.07M0.07M0.07M0.07M
Assets Average 119.87M154.98M136.68M117.50M95.56M72.52M88.14M
Equity Average -120.44M77.47M60.54M39.37M17.40M-5.92M-10.70M
Invested Capital -324.49M84.18M70.75M50.32M28.42M6.38M-18.21M-3.18M
Asset Utilization Ratio 0.000.000.000.000.000.000.00
Leverage & Solvency
Debt to Equity -0.170.340.400.601.064.61-1.65-9.68
Debt Ratio 0.730.180.190.240.280.350.480.27
Equity Ratio -4.270.510.480.400.260.08-0.29-0.03
Valuation
Enterprise Value -28.24M-121.76M-102.75M-84.66M-67.46M-42.11M-22.30M-77.70M
Return Ratios
Return on Sales -2,338.00%-162.79%-379.08%-1,788.29%-619.52%-502.56%-1,631.93%-8,161.33%-1,149.02%-2,784.18%-8,161.33%
Return on Capital Employed -0.57%-0.51%-0.67%-0.96%
Return on Assets -0.49%-0.44%-0.57%-0.76%-0.72%-0.65%-0.28%
Return on Equity 0.48%-0.88%-1.28%-2.27%-3.96%8.00%2.29%